Miranda Baumguardner
Family · Odessa, TXNPI 1730737214
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 76 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 21.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,116 and has fallen 79.9% since, to $224 in 2023.
Across 76 payments — averaging $27.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$455
- AstraZeneca$406
- AbbVie$227
- Amgen$222
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$116
- Potrero Medical, Inc.$111
- plus $551 from 13 others
What the payments were for
- Food & beverage$2,088100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 17 | $455 |
| AstraZeneca(2 entities) | 8 | $406 |
| AbbVie(2 entities) | 10 | $227 |
| Amgen | 10 | $222 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $116 |
| Potrero Medical, Inc. | 1 | $111 |
| Abbott | 1 | $108 |
| Biohaven Pharmaceuticals, Inc. | 6 | $101 |
| Boston Scientific | 3 | $63 |
| GSK | 4 | $60 |
| Sanofi-aventis U.S. LLC | 3 | $48 |
| Boehringer Ingelheim | 2 | $40 |
| Supernus Pharmaceuticals, Inc. | 2 | $29 |
| Amarin Pharma, Inc. | 2 | $26 |
| Eisai Inc. | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Saxenda$119
- FreeStyle Libre$108
- RYBELSUS$101
How this compares
$2,088 in reported general payments places this provider in the 80th percentile of 15,456 family providers in Texas.
Other family in Odessa
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.